English (United Kingdom)Русский (Russian Federation)

Company facts

Cromos Pharma is an independent US-based contract research organization (CRO), which was founded in 2005. We provide full range of services to pharmaceutical and biotechnology companies.

We manage Phase I-IV clinical trials in Russia and other Eastern European countries through our offices in Washington (USA), Moscow (Russia) and in Kiev (Ukraine). Services in Russia and Ukraine are provided by Cromos Pharma´s highly professional staff or via personnel of 3C Alliance. Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, successful patient recruitment is the integral to our goal of providing high quality and affordable services. We guarantee speed, quality, and best experts in the field. Intricate knowledge of the market, long-term working relationship with the best research centers and regulatory authorities give us a unique opportunity to accomplish the most difficult tasks in the shortest period of time.

In 2011 Cromos Pharma and two other Russian companies joined forces with creating a strategic alliance – 3C Alliance, that will provide unprecedented scope of services on the Russian clinical trials market.

Our diverse clinical experience, vast industry exposure, and first-rate services are all the necessary ingredients of your successful trial launch, on time and on budget.

Cromos Pharma  is a member of Russian Association of Clinical Trials Organizations (ACTO) – a non-commercial organization of the leading pharma companies and CROs involved in clinical trials in Russia, which has very strict selection criteria.

Cromos is a registered trade mark of Cromos Pharma company and its affiliates on the territory of Russia and USA.

 
News and messages from CEO,
Dr Vladimir Bogin
12.01.2012

Cromos Pharma has participated in the conference on clinical trials in emerging markets in Tel-Aviv, Israel on 11 January 2012.

[...]

05.01.2012

Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012.

[...]

14.12.2011

Cromos Pharma published a white paper with review of Russian clinical trials market in 2011.

[...]

28.10.2011

Cromos Pharma's CEO, Dr. Vladimir Bogin has participated in the annual Rusnanotech forum in Moscow, Russia on 25-28 October 2011 .

[...]

27.09.2011

Meet us at 17th Annual International Partnering Conference BIO-Europe 2011 in Duesseldorf, Germany on 31 October - 02 November 2011.

[...]